'A harrowing time.' Ten states reported their highest number of new coronavirus cases on Friday
Submitted by mike kraft on

Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
BERLIN (AP) — Chancellor Angela Merkel urged Germans to come together like they did in the spring to slow the spread of the coronavirus as the country posted another daily record of new cases Saturday.
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
WASHINGTON (AP) — Federal health officials on Friday unveiled a plan to get yet-to-be-approved coronavirus vaccines to nursing home residents free of charge, enlisting two national pharmacy chains to help.
Submitted by mike kraft on
A $5 rapid test for the coronavirus may be nearly as effective as the slower, more complex polymerase chain reaction test for identifying people who may spread the coronavirus, a novel experiment has found.
The study, conducted by scientists at the University of California, San Francisco, is among the first head-to-head comparisons of a rapid test and the P.C.R. diagnostic tool under real-world conditions.
But the number of participants was comparatively small, and the data have not been peer-reviewed or published. A rapid test still cannot conclusively determine that an individual is not infected; the tests are intended primarily to detect the presence of high levels of the virus, rather than its absence, and are authorized only to evaluate symptomatic people.
At the moment, anyone who has been exposed to the virus should be tested by P.C.R., said Joseph DeRisi, an infectious disease expert at U.C.S.F. and a co-leader of the project.
Submitted by mike kraft on
Submitted by mike kraft on
Facing public skepticism about rushed COVID-19 vaccines, U.S. health officials are planning extra scrutiny of the first people vaccinated when shots become available — an added safety layer experts call vital.
Submitted by mike kraft on
Submitted by mike kraft on
The chief executive of Pfizer said on Friday that the company would not apply for emergency authorization of its coronavirus vaccine before the third week of November, ruling out President Trump’s assertion that a vaccine would be ready before Election Day on Nov. 3.
Submitted by mike kraft on